Yoon-kyo K. An

South Brisbane, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

Extended High-Dose Tofacitinib Induction Improves Clinical Response in Ulcerative Colitis: A Multicenter Cohort Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: March 12, 2026

Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations.

Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations.

Journal: Inflammatory bowel diseases

Published: February 12, 2026

Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics.

Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging Therapeutics.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: January 16, 2026

Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfaction.

Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfaction.

Journal: Journal of Crohn's & colitis

Published: December 02, 2025

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial.

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial.

Journal: BMJ open gastroenterology

Published: September 22, 2025

Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.

Australian Real-World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the AURORA Study, Including the ANZIBD Consortium.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: September 05, 2025

Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists.

Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists.

Journal: Therapeutic advances in gastroenterology

Published: September 01, 2025

Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era.

Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era.

Journal: Inflammatory bowel diseases

Published: May 23, 2025

Acute Severe Ulcerative Colitis Patients From Asia Have Lower Colectomy Risk Than Patients From Australasia.

Acute Severe Ulcerative Colitis Patients From Asia Have Lower Colectomy Risk Than Patients From Australasia.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 23, 2025

Point-of-Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations.

Point-of-Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional Investigations.

Journal: Journal of gastroenterology and hepatology

Published: November 02, 2024

The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring.

The Durability of Anti-TNF Therapy for Crohn's Disease Is Higher in Anti-TNF Naïve Patients and Increases With Proactive Therapeutic Drug Monitoring.

Journal: Crohn's & colitis 360

Published: October 28, 2024

Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.

Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.

Journal: Journal of gastroenterology and hepatology

Published: October 25, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026